Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by deninsaskon Sep 09, 2007 11:54pm
294 Views
Post# 13365036

RE: Very Interesting......

RE: Very Interesting...... It seems to be exactly as I expected.....Novo and Transition are in serious negotiations for the whole kit 'n kaboodle.....the whole G1 based technology...... I.N.T. Technology Licensing Agreement. Management has extended the deadline with Novo Nordisk for negotiating rights to the I.N.T. technology. We believe that a decision could be reached during Q4/07 if TTH is able to achieve favourable terms. However, we believe TTH is open to negotiation with other potential partners, if necessary.
Bullboard Posts